Efficacy of adjuvant radiotherapy for atypical and anaplastic meningioma

70Citations
Citations of this article
67Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The effect of adjuvant radiotherapy in management for high-grade meningiomas, especially atypical meningiomas, remains controversial. We aimed to explore the role of adjuvant radiotherapy in this population. A total of 162 adults with high-grade meningiomas (99 atypical meningiomas and 63 anaplastic meningiomas) were treated from 2003 to 2008 at Huashan Hospital. One hundred and seventeen patients presented with primary and 45 with recurrent disease. One hundred and fifteen patients (70.9%) were treated with adjuvant radiotherapy after surgical resection. The median follow-up was 76.5 months (range 1-142 months). Kaplan-Meier survival curve and Cox proportional hazards modeling were used for analyses. Adjuvant radiotherapy was associated with prolonged progression-free survival (PFS) and overall survival (OS) in patients with newly diagnosed anaplastic meningiomas irrespective of extent of resection (PFS, P =.001; OS, P =.003). Gross total resection was the only independent prognostic factor for those with newly diagnosed atypical meningiomas (PFS, P

Cite

CITATION STYLE

APA

Zhu, H., Bi, W. L., Aizer, A., Hua, L., Tian, M., Den, J., … Gong, Y. (2019). Efficacy of adjuvant radiotherapy for atypical and anaplastic meningioma. Cancer Medicine, 8(1), 13–20. https://doi.org/10.1002/cam4.1531

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free